Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Acq. announced
Director departure
|
|
Adhera Therapeutics, Inc. (ATRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/28/2022 |
3
| RICE CHARLES L JR (Director) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 04/21/2022 |
3
| Waerness Trond Kydd (Director) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 11/29/2021 |
3
| Subhan Zahed (Director) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 07/20/2020 |
3
| KUCHARCHUK ANDREW ALBERT (CEO) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 11/05/2019 |
4
| Stanley Rhonda L. (SVP Finance & Accounting) has filed a Form 4 on Adhera Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.09, valued at
$31.5k
|
|
| 11/04/2019 |
3
| Stanley Rhonda L. (SVP Finance & Accounting) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 04/04/2019 |
4
| Phelan Nancy R. (CEO and Secretary) has filed a Form 4 on Adhera Therapeutics, Inc.|
Txns:
| Granted 1,500,000 options to buy
@ $0.37, valued at
$555k
|
|
| 01/17/2019 |
4
| Teague Robert Eric (CFO) has filed a Form 4 on Adhera Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.32, valued at
$32k
|
|
| 10/24/2018 |
3
| Phelan Nancy R. (Director) has filed a Form 3 on Adhera Therapeutics, Inc. |
| 10/04/2018 |
4
| Trieu Vuong (10% Owner) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Disposed/sold 500,000 shares
@ $0.5, valued at
$250k
|
|
| 09/26/2018 |
4
| Teague Robert Eric (CFO) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 450,000 options to buy
@ $0.55, valued at
$247.5k
|
|
| 09/26/2018 |
3
| Teague Robert Eric (CFO) has filed a Form 3 on Marina Biotech, Inc. |
| 07/16/2018 |
4
| Moscato Robert Jr. (CEO) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Bought 40 convertible preferred
@ $0.5, valued at
$20
Bought 300,000 options to buy
@ $0.55, valued at
$165k
|
|
| 07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2018 |
4
| Hacksell Uli (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.66, valued at
$660k
|
|
| 07/11/2018 |
4
| Moscato Robert Jr. (CEO) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 1,500,000 options to buy
@ $0.66, valued at
$990k
|
|
| 07/02/2018 |
3
| Hacksell Uli (Director) has filed a Form 3 on Marina Biotech, Inc. |
| 06/25/2018 |
3
| Moscato Robert Jr. (CEO) has filed a Form 3 on Marina Biotech, Inc. |
| 05/07/2018 |
3
| Boris Timothy (Director) has filed a Form 3 on Marina Biotech, Inc. |
| 05/04/2018 |
4
| Ramelli Joseph W. (Former Chief Executive Officer) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.98, valued at
$98k
|
|
| 05/04/2018 |
4
| Ranker Philip C (Former Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.98, valued at
$196k
|
|
| 05/04/2018 |
4
| Calais Philippe (Former Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.98, valued at
$78.4k
|
|
| 04/18/2018 |
4
| Trieu Vuong (Executive Chairman) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 2 convertible preferred
@ $0.5, valued at
$1.1
Granted 16,875 options to buy
@ $0.55, valued at
$9.3k
Converted 35 convertible preferred
@ $0.5, valued at
$17.3
Converted 258,825 options to buy
@ $0.55, valued at
$142.4k
Converted convertible notes
@ $5000, valued at
$0
Converted 115 convertible preferred
@ $0.5, valued at
$57.3
Converted 859,725 options to buy
@ $0.55, valued at
$472.8k
Converted options to buy
@ $5000, valued at
$0
Converted 19 convertible preferred
@ $0.5, valued at
$9.5
Converted 142,500 options to buy
@ $0.55, valued at
$78.4k
Converted options to buy
@ $5000, valued at
$0 |
|
| 04/18/2018 |
4
| Hwang Larn (Chief Scientific Officer) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Converted 10 convertible preferred
@ $0.5, valued at
$5.2
Converted 78,300 options to buy
@ $0.55, valued at
$43.1k
Converted convertible notes
@ $5000, valued at
$0 |
|
| 04/18/2018 |
4
| BLECH ISAAC (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 2 convertible preferred
@ $0.5, valued at
$1.1
Granted 16,875 options to buy
@ $0.55, valued at
$9.3k
Converted 104 convertible preferred
@ $0.5, valued at
$51.9
Converted 777,750 options to buy
@ $0.55, valued at
$427.8k
Converted convertible notes
@ $5000, valued at
$0 |
|
| 04/18/2018 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 18 convertible preferred
@ $0.5, valued at
$9
Granted 135,000 options to buy
@ $0.55, valued at
$74.3k
|
|
| 04/18/2018 |
4
| Ranker Philip C (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 18 convertible preferred
@ $0.5, valued at
$9
Granted 135,000 options to buy
@ $0.55, valued at
$74.3k
|
|
| 01/03/2018 |
4
| BLECH ISAAC (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 3,800 options to buy
@ $1.56, valued at
$5.9k
|
|
| 01/03/2018 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 3,800 options to buy
@ $1.56, valued at
$5.9k
|
|
| 01/03/2018 |
4
| Ranker Philip C (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 3,800 options to buy
@ $1.56, valued at
$5.9k
|
|
| 01/03/2018 |
4
| Calais Philippe (Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 3,800 options to buy
@ $1.56, valued at
$5.9k
|
|
| 01/03/2018 |
4
| Trieu Vuong (Executive Chairman) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 3,800 options to buy
@ $1.56, valued at
$5.9k
|
|
| 11/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2017 |
3
| BLECH ISAAC (Director) has filed a Form 3 on Marina Biotech, Inc. |
|
|
|